GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3451 - 3475 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G84224TW
358
IgA Patient 1 22 moderate
G84224TW
325
IgA Patient 1 6 moderate
G84224TW
312
IgG Patient 1 10 moderate
G84224TW
27
IgG Patient 1 22 moderate
G84224TW
36
IgM Patient 1 10 moderate
G84224TW
36
IgM Patient 1 22 moderate
G84224TW
47
IgG Patient 1 6 moderate
G84224TW
28
IgM Patient 1 6 moderate
G84224TW
34
IgA Patient 2 15 mild
G84224TW
344
IgA Patient 2 24 mild
G84224TW
525
IgG Patient 2 15 mild
G84224TW
73
IgG Patient 2 24 mild
G84224TW
105
IgM Patient 2 15 mild
G84224TW
72
IgA Patient 2 3 mild
G84224TW
553
IgG Patient 2 3 mild
G84224TW
127
IgM Patient 2 24 mild
G84224TW
75
IgM Patient 2 3 mild
G84224TW
93
IgA Patient 3 -180 mild
G84224TW
302
IgA Patient 3 11 mild
G84224TW
569
IgG Patient 3 -180 mild
G84224TW
56
IgM Patient 3 -180 mild
G84224TW
150
IgA Patient 3 4 mild
G84224TW
512
IgG Patient 3 11 mild
G84224TW
149
IgG Patient 3 4 mild
G84224TW
123

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024